Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2266004rdf:typepubmed:Citationlld:pubmed
pubmed-article:2266004lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:2266004lifeskim:mentionsumls-concept:C1819487lld:lifeskim
pubmed-article:2266004lifeskim:mentionsumls-concept:C1157383lld:lifeskim
pubmed-article:2266004lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:2266004lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:2266004pubmed:issue2lld:pubmed
pubmed-article:2266004pubmed:dateCreated1991-2-8lld:pubmed
pubmed-article:2266004pubmed:abstractTextModification of phospholipid metabolism during T cell activation has been repeatedly reported. Recently, we have shown that phytohaemagglutinin, CD3 and CD2 mAbs, which are potent in vitro activators of helper T lymphocytes, markedly inhibit phosphatidylserine synthesis concomitantly as they induce the secretion of IL-2. In this paper, we show evidence that in T lymphocytes K+ channels, which have been shown to participate in the cell activation process, are also reciprocally related to phosphatidylserine synthesis. In fact, in resting T cells the drugs affecting the activity of K+ channels, such as quinine and 4-aminopyridine, induce a rise of phosphatidylserine synthesis. In activated cells, quinine and 4-amidopyridine also caused a rise in phosphatidylserine synthesis which paralleled a decreased production of IL-2, strongly suggesting that these two events are correlated in a reciprocal manner. More precisely, phosphatidylserine synthesis was stimulated by drugs which have been reported to inhibit potassium channels in lymphocytes, e.g. quinine, 4-aminopyridine, tetraethylammonium. These data suggest that the decreased PS synthesis observed during T cell activation intervenes in the cascade of events leading to IL-2 secretion. The decrease in the biosynthesis of this phospholipid seems to be dependent on the activity of K+ channels.lld:pubmed
pubmed-article:2266004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:languageenglld:pubmed
pubmed-article:2266004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:citationSubsetIMlld:pubmed
pubmed-article:2266004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266004pubmed:statusMEDLINElld:pubmed
pubmed-article:2266004pubmed:issn0162-3109lld:pubmed
pubmed-article:2266004pubmed:authorpubmed-author:RossiBBlld:pubmed
pubmed-article:2266004pubmed:authorpubmed-author:AusselCClld:pubmed
pubmed-article:2266004pubmed:authorpubmed-author:MarxEElld:pubmed
pubmed-article:2266004pubmed:authorpubmed-author:ChoquetDDlld:pubmed
pubmed-article:2266004pubmed:authorpubmed-author:PelassyCClld:pubmed
pubmed-article:2266004pubmed:issnTypePrintlld:pubmed
pubmed-article:2266004pubmed:volume20lld:pubmed
pubmed-article:2266004pubmed:ownerNLMlld:pubmed
pubmed-article:2266004pubmed:authorsCompleteYlld:pubmed
pubmed-article:2266004pubmed:pagination97-103lld:pubmed
pubmed-article:2266004pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:meshHeadingpubmed-meshheading:2266004-...lld:pubmed
pubmed-article:2266004pubmed:articleTitleRegulation of interleukin-2 production and phosphatidylserine synthesis in Jurkat T lymphocytes by K+ channel antagonists.lld:pubmed
pubmed-article:2266004pubmed:affiliationUnité de Recherches en Immunologie Cellulaire et Moléculaire, INSERM U210 Faculté de Médecine (Pasteur), Nice, France.lld:pubmed
pubmed-article:2266004pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2266004pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2266004lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2266004lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2266004lld:pubmed